Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balakrishnan

Showing results (141-150 of 7,131) with videos related to

Pageof 714
Sort By:
The Lancet. Respiratory Medicine|August 7, 2023
Germany's cycling vision threatened by proposed budget cutsVijay Shankar Balakrishnan
Journal of the National Cancer Institute|December 7, 2016
Researchers Find New Chemoresistance Mechanism in BRCA-Deficient TumorsVijay Shankar Balakrishnan
The Indian Veterinary Journal|February 19, 2014
Studies in equine blood groupsC S BALAKRISHNAN
The Lancet. Infectious Diseases|April 19, 2025
The fallout of US HHS layoffs on infectious disease controlVijay Shankar Balakrishnan
The Lancet. Infectious Diseases|September 24, 2022
WHO's antibacterial pipeline reportsVijay Shankar Balakrishnan
The Lancet. Infectious Diseases|March 1, 2025
Global cholera resurgence-a preventable tragedyVijay Shankar Balakrishnan
Journal of the National Cancer Institute|September 6, 2015
Personalized Devices Predict Cancer Drug Sensitivity In VivoVijay Shankar Balakrishnan
The Lancet. Oncology|January 19, 2016
Patient risk factors versus physician guidelines for anti-emeticsVijay Shankar Balakrishnan
The Lancet. Oncology|June 5, 2015
Targetable mutations found in metastatic prostate cancerVijay Shankar Balakrishnan
The Lancet. Oncology|August 13, 2023
A legacy of war: cancer care fragmentation in IraqVijay Shankar Balakrishnan
Pageof 714

Showing results (141-150 of 7,131) with videos related to

Sort By:
Pageof 714
The Lancet. Respiratory Medicine|August 7, 2023
Germany's cycling vision threatened by proposed budget cutsVijay Shankar Balakrishnan
Journal of the National Cancer Institute|December 7, 2016
Researchers Find New Chemoresistance Mechanism in BRCA-Deficient TumorsVijay Shankar Balakrishnan
The Indian Veterinary Journal|February 19, 2014
Studies in equine blood groupsC S BALAKRISHNAN
The Lancet. Infectious Diseases|April 19, 2025
The fallout of US HHS layoffs on infectious disease controlVijay Shankar Balakrishnan
The Lancet. Infectious Diseases|September 24, 2022
WHO's antibacterial pipeline reportsVijay Shankar Balakrishnan
The Lancet. Infectious Diseases|March 1, 2025
Global cholera resurgence-a preventable tragedyVijay Shankar Balakrishnan
Journal of the National Cancer Institute|September 6, 2015
Personalized Devices Predict Cancer Drug Sensitivity In VivoVijay Shankar Balakrishnan
The Lancet. Oncology|January 19, 2016
Patient risk factors versus physician guidelines for anti-emeticsVijay Shankar Balakrishnan
The Lancet. Oncology|June 5, 2015
Targetable mutations found in metastatic prostate cancerVijay Shankar Balakrishnan
The Lancet. Oncology|August 13, 2023
A legacy of war: cancer care fragmentation in IraqVijay Shankar Balakrishnan
Pageof 714